Skip to main navigation Skip to search Skip to main content

Investigating the efficacy of TP-3654 in patients with myelofibrosis: results from Phase I study

Activity: Other

Description

64th ASH Annual Meeting and Exposition congress in New Orleans
PeriodDec 13 2022